DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

JMP Securities Downgrades Aimmune Therapeutics to Market Perform

JMP Securities analyst Liisa Bayko downgrades Aimmune Therapeutics (NASDAQ:AIMT) from Market Outperform to Market Perform.

Benzinga · 03/18/2020 11:10

JMP Securities analyst Liisa Bayko downgrades Aimmune Therapeutics (NASDAQ:AIMT) from Market Outperform to Market Perform.